DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,139,533 | +3.9% | 48,930 | +0.5% | 1.72% | +9.0% |
| Q2 2023 | $11,686,800 | +4.6% | 48,695 | +9.8% | 1.58% | +1.3% |
| Q1 2023 | $11,175,202 | -3.0% | 44,339 | +2.2% | 1.56% | -10.1% |
| Q4 2022 | $11,516,574 | +4.8% | 43,390 | +2.0% | 1.74% | -4.8% |
| Q3 2022 | $10,988,000 | +1.6% | 42,540 | -0.3% | 1.82% | +5.7% |
| Q2 2022 | $10,814,000 | -12.5% | 42,654 | +1.3% | 1.73% | +7.8% |
| Q1 2022 | $12,356,000 | -10.3% | 42,123 | +0.6% | 1.60% | -6.4% |
| Q4 2021 | $13,778,000 | +7.8% | 41,876 | -0.3% | 1.71% | +4.6% |
| Q3 2021 | $12,785,000 | +5.0% | 41,996 | -7.5% | 1.64% | +11.4% |
| Q2 2021 | $12,178,000 | +19.3% | 45,378 | +0.1% | 1.47% | +12.5% |
| Q1 2021 | $10,206,000 | -2.7% | 45,343 | -4.0% | 1.30% | -6.2% |
| Q4 2020 | $10,492,000 | -2.1% | 47,232 | -5.1% | 1.39% | -15.5% |
| Q3 2020 | $10,712,000 | +2.2% | 49,747 | -16.1% | 1.65% | -1.8% |
| Q2 2020 | $10,485,000 | +23.8% | 59,295 | -3.1% | 1.68% | +4.6% |
| Q1 2020 | $8,471,000 | +25.5% | 61,204 | +39.1% | 1.60% | +69.6% |
| Q4 2019 | $6,752,000 | +6.0% | 43,994 | -0.3% | 0.95% | -4.4% |
| Q3 2019 | $6,372,000 | +1.3% | 44,121 | +0.2% | 0.99% | +23.8% |
| Q2 2019 | $6,291,000 | -30.1% | 44,016 | -35.4% | 0.80% | -37.2% |
| Q1 2019 | $8,997,000 | +23.8% | 68,147 | -3.3% | 1.27% | +3.7% |
| Q4 2018 | $7,269,000 | -7.3% | 70,495 | -2.3% | 1.23% | +6.3% |
| Q3 2018 | $7,841,000 | +10.8% | 72,163 | +0.6% | 1.15% | -10.1% |
| Q2 2018 | $7,077,000 | -0.9% | 71,713 | -1.7% | 1.28% | -1.2% |
| Q1 2018 | $7,144,000 | +8.4% | 72,962 | +2.8% | 1.30% | +10.8% |
| Q4 2017 | $6,589,000 | +7.1% | 70,982 | -1.1% | 1.17% | +5.6% |
| Q3 2017 | $6,155,000 | +5.1% | 71,757 | +3.4% | 1.11% | -29.1% |
| Q2 2017 | $5,859,000 | -3.8% | 69,431 | +5.9% | 1.57% | -38.9% |
| Q4 2015 | $6,089,000 | +3.4% | 65,561 | -5.2% | 2.56% | +4.5% |
| Q3 2015 | $5,891,000 | +3.7% | 69,137 | +4.2% | 2.45% | +12.4% |
| Q2 2015 | $5,681,000 | +5.8% | 66,369 | +4.9% | 2.18% | +39.7% |
| Q1 2015 | $5,372,000 | -1.4% | 63,276 | -0.5% | 1.56% | +7.7% |
| Q4 2014 | $5,451,000 | +12.0% | 63,601 | -0.7% | 1.45% | -0.2% |
| Q3 2014 | $4,866,000 | +18.4% | 64,042 | +22.6% | 1.45% | +12.9% |
| Q2 2014 | $4,111,000 | +21.0% | 52,216 | +15.3% | 1.29% | +16.7% |
| Q1 2014 | $3,398,000 | -0.1% | 45,301 | +2.8% | 1.10% | +0.2% |
| Q4 2013 | $3,403,000 | +9.1% | 44,085 | -2.0% | 1.10% | +7.9% |
| Q3 2013 | $3,118,000 | +21.3% | 44,985 | +10.8% | 1.02% | +9.6% |
| Q2 2013 | $2,570,000 | – | 40,605 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |